Jul 11, 2019
Regulatory Trends in Select Asian Bone Mineral Density Solutions, 2019 Report - ResearchAndMarkets.com
Feb 25, 2019
Exalenz Bioscience Receives Approval for Commercial Marketing in China for Its BreathID® Hp Lab System
Dec 27, 2018
China's NMPA Approves Innovent's Anti-PD-1 Antibody Tyvyt® (Sintilimab injection) for Hodgkin's Lymphoma
Oct 25, 2018
Novel Drug Treatment Shows Improved Cognition in a Phase 3 Clinical Trial in Persons with Mild-to-Moderate Alzheimer's Disease in China
Oct 18, 2018
Ascletis' Ravidasvir NDA Proposed for Priority Review by the CFDA
Oct 08, 2018
Yisheng Biopharma Announces Clearance from China FDA to Proceed with PIKA Rabies Vaccine Clinical Study
Aug 22, 2018
Genetron Healths' biochip reader GENETRON 3D had received the approval for launch to faclitate liquid biopsy of tumor
Aug 20, 2018
UL Signs Exclusive Memorandum of Understanding with the China Food and Drug Administration's Institute of Executive Development
Aug 01, 2018
Ascletis' NDA for Its All-oral HCV Treatment Accepted by CFDA
May 07, 2018
CANbridge Life Sciences Appoints Vice President of Clinical Development and Medical Affairs and Director of Quality Assurance
May 02, 2018
ArisGlobal Introduces LifeSphere Safety MultiVigilance(TM) Pharmacovigilance Solution for China
Apr 24, 2018
MCRA Offers Informational Presentation on Medical Device Regulation to the Chinese FDA
Jan 16, 2018
CANbridge Life Sciences Appoints Vice President of Regulatory Affairs and Quality
Jan 08, 2018
Ascentage Pharma Announces Acceptance of IND Application by China FDA for Clinical Study of Novel IAP Inhibitor to Treat Hepatitis B Infection
Dec 18, 2017
MCRA Offers Informational Presentation on Medical Device Regulation to the Chinese FDA
Sep 07, 2017
CASI Provides Pipeline Development Update